ICAM1 and Sepsis: The other two studies by Yang et al. and Liu et al. utilized γ3 peptide (NNQKIVNLKEKVAQLEA) as an ICAM-1 ligand for surface modification of PLGA nanoparticles achieving targeted release of the loaded antisepsis agents at the sepsis’s inflamed sites.